ADMA Biologics (ADMA) 10-K2022 FY Annual report

Filed: 23 Mar 23, 5:16pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: Beneficiary, BlackRock, breadth, Caligan, Colorado, Connecticut, deceive, deliberate, disregard, driven, drove, ethical, falsity, FCA, freight, fuel, geopolitical, Healix, IEI, illegal, illegitimate, Inborn, interoperable, janitorial, meaningfully, mutating, nonclinical, noteholder, NWQ, passage, postage, proof, ramping, recession, recessionary, se, South, supplier, translate, truth, unchanged, unemployment, Utah, Vanguard, variant, Virginia, war, wrote

Removed: assumption, beneficially, Biolife, drafting, evidenced, exceeding, excluding, exemption, favor, gave, GMP, LIBOR, measurement, multiplied, notably, OCR, pledged, promissory, qui, rental, subordinated, tam, Trust, uncovering, update, vi, VWAP

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated ADMA transcripts

ADMA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 21.1

ADMA BioCenters Georgia Inc.

Jurisdiction of incorporation:	Delaware

Name under which business conducted:	ADMA BioCenters Georgia Inc.

ADMA Plasma Biologics, Inc.

Jurisdiction of incorporation:	Delaware

Name under which business conducted:	ADMA Plasma Biologics, Inc.

ADMA BioManufacturing, LLC

Jurisdiction of incorporation:	Delaware

Name under which business conducted:	ADMA BioManufacturing, LLC